Latest Kaiser Health News Stories
FAQ: How Does New Trump Fetal Tissue Policy Impact Medical Research?
The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.
KHN’s ‘What The Health?’: Fetal Tissue Research Is Latest Flashpoint In Abortion Debate
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss the Trump administration’s efforts to curtail federally funded research using fetal tissue, the backlash from former Vice President Joe Biden’s support for the anti-abortion Hyde Amendment and how health policy intersects with both trade and immigration policy.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Pacientes experimentan con drogas recetadas para luchar contra la vejez
Aún no se han realizado ensayos clínicos rigurosos a gran escala para estudiar el proceso de envejecimiento. Así y todo, pacientes experimentan con drogas para detener el paso del tiempo.
Patients Experiment With Prescription Drugs To Fight Aging
Doctors and patients say they’re compelled to use off-label meds as research goes unfunded.
Trump’s Pediatric Cancer Crusade A Drop In Bucket Compared With Past Presidential Pitches
President Donald Trump wants Congress to allot $500 million over 10 years for pediatric cancer research. While it’s welcomed by researchers and advocates, it’s not a lot of money.
John Dingell, ‘Dean Of The House,’ Remembered As A Force In Health Policy
The Michigan Democrat chaired the House Energy and Commerce Committee and his impact on health care was immense.
Podcast: KHN’s ‘What The Health?’ A ‘Healthy’ State Of The Union
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
How The Shutdown Might Affect Your Health
For some federal health programs, a shuttered government means business as usual. But the congressional impasse over funding will hit others hard.
A Busy Week For Health: Budget Cuts, CBO Scores And Mitch McConnell’s Cryptic Signal
KHN’s Mary Agnes Carey and Julie Rovner discuss some of the developments that shook up health news this week.
Stalking the ‘Unknown Enemy’: Doctors Turn Scope On Rare Diseases
An NIH-funded network of hospitals uses advanced genetic science and nationwide collaboration to diagnose rare and sometimes undiscovered diseases.
Researchers Call Trump’s Proposed NIH Cuts ‘Shocking’
Among the institutions that stand to lose most are those in California, especially the University of California and Stanford University.
Zika: brotes por el calor pueden acelerar una vacuna
Mientras las temperaturas más cálidas anuncian la llegada de mosquitos molestos, los investigadores están trabajando febrilmente en varias vacunas prometedoras contra el zika… pero hace falta un brote para probarlas.
Sprint To Find Zika Vaccine Could Hinge On Summer Outbreaks
In a paradox, researchers say testing for a vaccine will depend on the outbreak recurring this year.
Many Doctors Treating Alcohol Problems Overlook Successful Drugs
Two prescription medications have been found to be successful in helping many patients with alcohol cravings. Yet they are rarely used and many patients don’t know they exist.
Warning: Government Listing Of Clinical Trials Doesn’t Disclose Costs To Patients
Some clinics on NIH’s website charge people to participate in testing of unproven treatments — and it can come as a surprise to unsuspecting patients.
NIH’s Fauci On Combating Zika: ‘You Have To Have The Resources To Act Quickly’
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, recently spoke with KHN’s Carmen Heredia Rodriguez about vaccine development and the ongoing fight in Congress over emergency funding.
Report: ‘Convergence Science’ Has Potential To Accelerate The Research-To-Product Pipeline
Some say this trend is the future of biomedical research. But along with its potential, it also faces significant challenges.
Study Promotes Battlefields’ Lessons To Advance National Trauma Care
A report from the National Academies of Sciences, Engineering and Medicine calls for the White House to lead a national strategy to promote and continue advances in trauma care.
Senate Panel Kills Medicare Program That Offers Help On Enrollment, Billing Issues
It’s not clear yet if the full Senate or House will concur in the plan to cut funding for the State Health Insurance Assistance Program, which operates in all states and gives beneficiaries free advice on enrollment in drug and insurance plans, appealing coverage decisions and applying for financial subsidies.